- Home
- CSBR vs BWG Comparison
CSBR vs BWG Comparison
Compare CSBR & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- BWG
- Stock Information
- Founded
- CSBR 1985
- BWG 2012
- Country
- CSBR United States
- BWG United States
- Employees
- CSBR N/A
- BWG N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- BWG Finance/Investors Services
- Sector
- CSBR Health Care
- BWG Finance
- Exchange
- CSBR Nasdaq
- BWG Nasdaq
- Market Cap
- CSBR 151.0M
- BWG 138.7M
- IPO Year
- CSBR 1986
- BWG N/A
- Fundamental
- Price
- CSBR $10.17
- BWG $8.43
- Analyst Decision
- CSBR Strong Buy
- BWG
- Analyst Count
- CSBR 1
- BWG 0
- Target Price
- CSBR $8.00
- BWG N/A
- AVG Volume (30 Days)
- CSBR 46.1K
- BWG 53.8K
- Earning Date
- CSBR 03-11-2025
- BWG 01-01-0001
- Dividend Yield
- CSBR N/A
- BWG 11.37%
- EPS Growth
- CSBR N/A
- BWG N/A
- EPS
- CSBR N/A
- BWG N/A
- Revenue
- CSBR $53,571,000.00
- BWG N/A
- Revenue This Year
- CSBR $14.19
- BWG N/A
- Revenue Next Year
- CSBR $10.11
- BWG N/A
- P/E Ratio
- CSBR N/A
- BWG N/A
- Revenue Growth
- CSBR 7.19
- BWG N/A
- 52 Week Low
- CSBR $3.60
- BWG $6.86
- 52 Week High
- CSBR $11.99
- BWG $8.65
- Technical
- Relative Strength Index (RSI)
- CSBR 48.12
- BWG 59.81
- Support Level
- CSBR $10.32
- BWG $8.31
- Resistance Level
- CSBR $11.33
- BWG $8.55
- Average True Range (ATR)
- CSBR 0.99
- BWG 0.08
- MACD
- CSBR -0.20
- BWG 0.01
- Stochastic Oscillator
- CSBR 29.57
- BWG 65.71
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.